First Trust NYSE Arca Biotechnology Index Fund (FBT) — ETF Analysis on Winston

Key Facts

• Issuer: First Trust
• Asset Class: Stock
• Price: $271.07
• Expense Ratio: 55.00%
• Assets Under Management: $2.8B
• Number of Holdings: 30
• Inception Date: 2006-06-19
• Currency: USD

Winston Score

First Trust NYSE Arca Biotechnology Index Fund has a Winston Score of 69 out of 100.

Performance

• 1-Year Return: 58.35%
• 3-Year Return: 77.94%
• 5-Year Return: 57.29%

Top Holdings

Halozyme Therapeutics, Inc. (N/A%), Corcept Therapeutics Inc. (N/A%), Natera, Inc. (N/A%), Regeneron Pharmaceuticals, Inc. (N/A%), NeoGenomics, Inc. (N/A%)

Sector Breakdown

Healthcare (N/A%)